Skip to main content
SpringerLink
Log in

Mesenchymal Stem Cell Identification After Delayed Cord Clamping

  • Regenerative Medicine: Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

A Correction to this article was published on 02 February 2023

This article has been updated

Abstract

We sought to determine the feasibility of identifying and quantifying mesenchymal stem cells (MSCs) from umbilical cord blood (UCB) after delayed cord clamping in preterm and term births. We obtained 3 mL of UCB at various gestational ages after delayed cord clamping. UCB separated by density gradient centrifugation within 4 h of delivery was passed through magnetic bead micro-columns to exclude the CD34 + cell population. The samples were incubated with fluorescent-tagged mesenchymal cell marker antibodies CD 29, CD44, CD73, CD105, and hematopoietic cell marker CD45. The cell populations were analyzed by flow cytometry. Viable cells were assessed with 7-aminoactinomycin-D. The results were expressed in median (minimum to maximum) MSCs and compared between preterm and term samples. A total of 12 UCB samples (32–40 weeks) were obtained, 10 of which demonstrated MSCs, accounting for 0.0174% (0–14.7%) of the viable UCB mononuclear cells. MSCs comprised 0.148% (0.0006–1.59%) and 0.116% (0–14.7%) of the viable UCB mononuclear cells in the term (n = 5), 38.4 ± 1.3 weeks, and preterm (n = 7) samples, 34.6 ± 1.1, respectively, p = 0.17. There was an overall median of 96 (0–39,574) MSCs. There was no difference in the median numbers of MSCs identified between term and preterm UCB samples, 3384 (23–6042) and 36 (0–39,574), respectively, p = 0.12. Mesenchymal stem cells were identified and quantified in 5 of 7 preterm and all 5 term UCB 3-mL samples obtained after delayed cord clamping.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The authors confirm that the data supporting the findings are contained within the manuscript.

Code Availability

Not applicable.

Change history

References

  1. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol. 1998;176:57–66. https://doi.org/10.1002/(SICI)1097-4652(199807)176:1%3c57::AID-JCP7%3e3.0.CO;2-7.

    Article  CAS  PubMed  Google Scholar 

  2. Divya MS, Roshin GE, Divya TS, Rasheed VA, Santhoshkumar TR, Elizabeth KE, et al. Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation. Stem Cell Res Ther. 2012;3:57. https://doi.org/10.1186/scrt148.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Jaing TH. Umbilical cord blood: a trustworthy source of multipotent stem cells for regenerative medicine. Cell Transplant. 2014;23:493–6. https://doi.org/10.3727/096368914X678300.

    Article  PubMed  Google Scholar 

  4. Christodoulou I, Kolisis FN, Papaevangeliou D, Zoumpourlis V. Comparative evaluation of human mesenchymal stem cells of fetal (Wharton’s jelly) and adult (adipose tissue) origin during prolonged in vitro expansion: considerations for cytotherapy. Stem Cells Int. 2013;2013:246134. https://doi.org/10.1155/2013/246134.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther. 2007;2:301–9. https://doi.org/10.2174/157488807782793790.

    Article  CAS  PubMed  Google Scholar 

  6. Tyndall A, Walker UA, Cope A, Dazzi F, De Bari C, Fibbe W, et al. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther. 2007;9:301. https://doi.org/10.1186/ar2103.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42–8. https://doi.org/10.1016/s0301-472x(01)00769-x.

    Article  PubMed  Google Scholar 

  8. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363(9419):1439–41. https://doi.org/10.1016/S0140-6736(04)16104-7.

    Article  PubMed  Google Scholar 

  9. Wu XQ, Yan TZ, Wang ZW, Wu X, Cao GH, Zhang C. BM-MSCs-derived microvesicles promote allogeneic kidney graft survival through enhancing micro-146a expression of dendritic cells. Immunol Lett. 2017;191:55–62. https://doi.org/10.1016/j.imlet.2017.09.010.

    Article  CAS  PubMed  Google Scholar 

  10. Pappas A, Shankaran S, McDonald SA, Vohr BR, Hintz SR, Ehrenkranz RA, et al. Hypothermia extended follow-up subcommittee of the Eunice Kennedy Shriver NICHD Neonatal Research Network Cognitive outcomes after neonatal encephalopathy. Pediatrics. 2015;135:e624–34. https://doi.org/10.1542/peds.2014-1566.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Drommelschmidt K, Serdar M, Bendix I, Herz J, Bertling F, Prager S, et al. Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav Immun. 2017;60:220–32. https://doi.org/10.1016/j.bbi.2016.11.011.

    Article  CAS  PubMed  Google Scholar 

  12. Wagenaar N, Nijboer CH, van Bel F. Repair of neonatal brain injury: bringing stem cell-based therapy into clinical practice. Dev Med Child Neurol. 2017;59:997–1003. https://doi.org/10.1111/dmcn.13528.

    Article  PubMed  Google Scholar 

  13. Paton MCB, McDonald CA, Allison BJ, Fahey MC, Jenkin G, Miller SL. Perinatal brain injury as a consequence of preterm birth and intrauterine inflammation: designing targeted stem cell therapies. Front Neurosci. 2017;11:200. https://doi.org/10.3389/fnins.2017.00200.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91:1017–26.

    CAS  PubMed  Google Scholar 

  15. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7. https://doi.org/10.1080/14653240600855905.

    Article  CAS  PubMed  Google Scholar 

  16. Sibov TT, Severino P, Marti LC, Pavon LF, Oliveira DM, Tobo PR, et al. Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation. Cytotechnology. 2012;64:511–21. https://doi.org/10.1007/s10616-012-9428-3.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica. 2001;86:1099–100.

    CAS  PubMed  Google Scholar 

  18. Erices A, Conget P, Minguell J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235–42.

    Article  CAS  PubMed  Google Scholar 

  19. Javed MJ, Mead LE, Prater D, Bessler WK, Foster D, Case J, et al. Endothelial colony forming cells and mesenchymal stem cells are enriched at different gestational ages in human umbilical cord blood. Pediatr Res. 2008;64:68–73. https://doi.org/10.1203/PDR.0b013e31817445e9.

    Article  PubMed  Google Scholar 

  20. Kc A, Rana N, Målqvist M, Jarawka Ranneberg L, Subedi K, Andersson O. Effects of delayed umbilical cord clamping vs early clamping on anemia in infants at 8 and 12 months. JAMA Pediatr. 2017;171:264. https://doi.org/10.1001/jamapediatrics.2016.3971.

    Article  PubMed  Google Scholar 

  21. American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Delayed umbilical cord clamping after birth: ACOG Committee Opinion, Number 814. Obstet Gynecol. 2020;136:e100–6. https://doi.org/10.1097/AOG.0000000000004167.

    Article  Google Scholar 

  22. Allan DS, Scrivens N, Lawless T, Mostert K, Oppenheimer L, Walker M, et al. Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking. Transfusion. 2016;56:662–5. https://doi.org/10.1111/trf.13424.

    Article  PubMed  Google Scholar 

  23. Podestà M, Bruschettini M, Cossu C, Sabatini F, Dagnino M, Romantsik O, et al. Preterm cord blood contains a higher proportion of immature hematopoietic progenitors compared to term samples. PLoS One. 2015;10(9):e0138680. https://doi.org/10.1371/journal.pone.0138680.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem. 2011;112:1206–18. https://doi.org/10.1002/jcb.23042.

    Article  CAS  PubMed  Google Scholar 

  25. Mansilla E, Marín GH, Drago H, Sturla F, Salas E, Gardiner C, et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc. 2006;38:967–9. https://doi.org/10.1016/j.transproceed.2006.02.053.

    Article  CAS  PubMed  Google Scholar 

  26. Frändberg S, Waldner B, Konar J, Rydberg L, Fasth A, Holgersson J. High quality cord blood banking is feasible with delayed clamping practices. The eight-year experience and current status of the national Swedish Cord Blood Bank. Cell Tissue Bank. 2016;17:439–48. https://doi.org/10.1007/s10561-016-9565-6.

    Article  PubMed  Google Scholar 

  27. Park WS, Sung SI, Ahn SY, Yoo HS, Sung DK, Im GH, et al. Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy. Baud O, ed. PLoS ONE. 2015;10(3):e0120893. https://doi.org/10.1371/journal.pone.0120893.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Ahn SY, Chang YS, Sung DK, Sung SI, Yoo HS, Im GH, et al. Optimal Route for mesenchymal stem cells transplantation after severe intraventricular hemorrhage in newborn rats. PLoS ONE. 2015;10(7):e0132919. https://doi.org/10.1371/journal.pone.0132919.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Chen G, Wang Y, Xu Z, Fang F, Xu R, Wang Y, et al. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J Transl Med. 2013;11:21. https://doi.org/10.1186/1479-5876-11-21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge Kent E. Vrana, PhD, for provision of laboratory assistance in the department of pharmacology. We thank Nate Sheaffer from Penn State College of Medicine’s Flow Cytometry Core (RRID:SCR_021134) for assistance with flow cytometry analysis.

Funding

Funding for the study was provided by the Division of Maternal–Fetal Medicine and the Department of Obstetrics and Gynecology, Penn State College of Medicine.

Author information

Authors and Affiliations

  1. Division of Maternal-Fetal Medicine, Department of Obstetrics, Penn State College of Medicine, Penn State Health, Milton S. Hershey Medical Center, Hershey, PA, USA

    Emily R. Smith, William M. Curtin & Serdar H. Ural

  2. Current Affiliation: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA

    Emily R. Smith

  3. Department of Pathology and Laboratory Medicine, Penn State Health, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

    William M. Curtin

  4. Department of Obstetrics, Penn State College of Medicine, Penn State Health, Milton S. Hershey Medical Center, Hershey, PA, USA

    Kevin P. Yeagle

  5. Department of Pharmacology, Penn State College of Medicine, Hershey, PA, USA

    Nurgul Carkaci-Salli

Authors
  1. Emily R. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William M. Curtin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin P. Yeagle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nurgul Carkaci-Salli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Serdar H. Ural
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to study conception and design. Material preparations, data collection, and analysis were performed by Emily R. Smith, MD, Kevin P. Yeagle, MD, and Nurgul Salli, PhD. William M. Curtin, MD, assisted with analysis and display of data. The first draft of the manuscript was provided by Dr. Smith. Drs. Smith and Curtin revised and edited the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to William M. Curtin.

Ethics declarations

Ethics Approval

The Human Subjects Protection Office of the institutional review board approval was obtained prior to initiation of the study (PRAMS031730EP).

Consent to Participate

Informed consent was completed with patients prior to sample processing.

Consent to Publish

Informed consent and IRB approval included consent to publish.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The work was presented in poster format at the Society for Reproductive Investigation 68th Annual Scientific Meeting on July 8, 2021, in Boston, Massachusetts.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, E.R., Curtin, W.M., Yeagle, K.P. et al. Mesenchymal Stem Cell Identification After Delayed Cord Clamping. Reprod. Sci. 30, 1565–1571 (2023). https://doi.org/10.1007/s43032-022-01129-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43032-022-01129-0

Keywords

Search

Navigation